October 2024 - Portal presented the poster "Addressing the Challenges of Highly Viscous Formulations Using a Needle-Free Technology" at the The PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Arizona.
October 2024 - Portal recently shared its latest research at The PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Arizona. The poster "Addressing the Challenges of Highly Viscous Formulations
Using a Needle-Free Technology" showed ex-vivo testing results which demonstrated PRIME Needle-Free injector can eject consistently and faster than a needle and syringe, while depositing the injectate at a similar depth in the subcutaneous space.
The ability for PRIME NF to eject high viscosity fluids consistently and rapidly could open the doors for new therapies as well as increase patient access to a more agreeable method of drug delivery. Having a needle-free system not only quells the common fear of needles but also boasts faster and more reliable injection times than a mechanical autoinjector. The findings of this study hint at the prospect of pushing beyond the constraints imposed by current needle-based injection devices.
September 2021 - Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
May 9, 2022 - Gerresheimer AG, a leading provider of drug delivery systems, is expanding its portfolio of highly innovative platform technologies for drug delivery, today announcing an investment into US-based Portal Instruments.
Portal Instruments, a leader in patient-centric drug delivery innovation, is pleased to announce the publication of a collaborative study in the journal Bioengineering & Translational Medicine, highlighting the viability of its next-generation, needle-free injector (NFI) fo
Please fill out the details below and we will get back to you shortly.